{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:45:16Z","timestamp":1790700316574,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2002,12,1]],"date-time":"2002-12-01T00:00:00Z","timestamp":1038700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2002,12,1]],"date-time":"2002-12-01T00:00:00Z","timestamp":1038700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2002,12,1]]},"DOI":"10.1038\/sj.bmt.1703819","type":"journal-article","created":{"date-parts":[[2002,12,13]],"date-time":"2002-12-13T06:57:22Z","timestamp":1039762642000},"page":"813-831","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Increasing use of reduced intensity conditioning transplants: report of the 2001 EBMT activity survey"],"prefix":"10.1038","volume":"30","author":[{"given":"A","family":"Gratwohl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Baldomero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Passweg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Urbano-Ispizua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Accreditation Committee of the European Group for Blood and Marrow Transplantation (EBMT)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2002,12,12]]},"reference":[{"key":"BF1703819_CR1","first-page":"95","volume":"36","author":"ED Thomas","year":"1999","unstructured":"Thomas ED . Bone marrow transplantation: a review Semin Hematol 1999 36: (Suppl. 7) 95 103","journal-title":"Semin Hematol"},{"key":"BF1703819_CR2","volume-title":"Hematopoietic Cell Transplantation, 2nd edn","author":"SJ Forman","year":"1998","unstructured":"Forman SJ, Blume KG, Thomas ED (eds). Hematopoietic Cell Transplantation, 2nd edn Blackwell Scientific Publishers: London, New York 1998"},{"key":"BF1703819_CR3","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1136\/bmj.321.7258.433","volume":"321","author":"AL Lennard","year":"2000","unstructured":"Lennard AL, Jackson GH . Stem cell transplantation Br Med J 2000 321: 433 437","journal-title":"Br Med J"},{"key":"BF1703819_CR4","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/sj.bmt.1703535","volume":"29","author":"A Urbano-Ispizua","year":"2002","unstructured":"Urbano-Ispizua A, Schmitz N, de Witte T et al. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe Bone Marrow Transplant 2002 29: 639 646","journal-title":"Bone Marrow Transplant"},{"key":"BF1703819_CR5","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/sj.bmt.1703382","volume":"29","author":"LL Popplewell","year":"2002","unstructured":"Popplewell LL, Forman SJ . Is there an upper age limit for bone marrow transplantation? Bone Marrow Transplant 2002 29: 272 284","journal-title":"Bone Marrow Transplant"},{"key":"BF1703819_CR6","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/S0140-6736(98)03030-X","volume":"352","author":"A Gratwohl","year":"1998","unstructured":"Gratwohl A, Hermans J, Goldman JM, Arcese W . Risk assessment for patients with chronic myeloid leukemia before allogeneic blood or marrow transplantation. Chronic Leukemia Working Party of the EBMT Lancet 1998 352: 1087 1092","journal-title":"Lancet"},{"key":"BF1703819_CR7","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/S1470-2045(01)00455-7","volume":"2","author":"S Slavin","year":"2001","unstructured":"Slavin S . Immunotherapy of cancer with alloreactive lymphocytes Lancet Oncol 2001 2: 491 498","journal-title":"Lancet Oncol"},{"key":"BF1703819_CR8","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1111\/j.1749-6632.2001.tb03601.x","volume":"938","author":"L Feinstein","year":"2001","unstructured":"Feinstein L, Sandmaier B, Maloney D et al. Nonmyeloablative hematopoietic cell transplantation. Replacing high-dose cytotoxic therapy by the graft-versus-tumor effect Ann N Y Acad Sci 2001 938: 328 337","journal-title":"Ann N Y Acad Sci"},{"key":"BF1703819_CR9","doi-asserted-by":"publisher","first-page":"3390","DOI":"10.1182\/blood.V97.11.3390","volume":"97","author":"PA McSweeney","year":"2001","unstructured":"McSweeney PA, Niederwieser D, Shizuru JA et al. Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects Blood 2001 97: 3390 3400","journal-title":"Blood"},{"key":"BF1703819_CR10","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/978-1-4615-4987-1_5","volume":"101","author":"S Giralt","year":"1999","unstructured":"Giralt S, Khouri I, Champlin R . Non myeloablative \u2018mini transplants\u2019 Cancer Treat Res 1999 101: 97 108","journal-title":"Cancer Treat Res"},{"key":"BF1703819_CR11","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/sj.bmt.1703355","volume":"29","author":"A Bacigalupo","year":"2002","unstructured":"Bacigalupo A . Second EBMT Workshop on reduced intensity allogeneic hemopoietic stem cell transplants (RI-HSCT) Bone Marrow Transplant 2002 29: 191 195","journal-title":"Bone Marrow Transplant"},{"key":"BF1703819_CR12","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1046\/j.1365-2141.2000.02405.x","volume":"111","author":"J Barrett","year":"2000","unstructured":"Barrett J, Childs R . Non-myeloablative stem cell transplants Br J Haematol 2000 111: 6 17","journal-title":"Br J Haematol"},{"key":"BF1703819_CR13","first-page":"197","volume":"8","author":"A Gratwohl","year":"1991","unstructured":"Gratwohl A . Bone marrow transplantation activity in Europe 1990. Report from the European Group for Bone Marrow Transplantation (EBMT) Bone Marrow Transplant 1991 8: 197 201","journal-title":"Bone Marrow Transplant"},{"key":"BF1703819_CR14","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1046\/j.1365-2141.2002.03440.x","volume":"117","author":"A Gratwohl","year":"2002","unstructured":"Gratwohl A, Passweg J, Baldomero H et al for the Accreditation Committee of the European Group for Blood and Marrow Transplantation (EBMT). Economics, health care systems and utilisation of haematopoietic stem cell transplants in Europe Br J Haematol 2002 117: 451 468","journal-title":"Br J Haematol"},{"key":"BF1703819_CR15","doi-asserted-by":"publisher","first-page":"2374","DOI":"10.1182\/blood-2002-03-0675","volume":"100","author":"A Gratwohl","year":"2002","unstructured":"Gratwohl A, Baldomero H, Horisberger B, Schmid C . Current trends in hematopoietic stem cell transplantation in Europe Blood 2002 100: 2374 2386","journal-title":"Blood"},{"key":"BF1703819_CR16","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/S0025-7753(01)71911-2","volume":"116","author":"A Salar","year":"2001","unstructured":"Salar A, Prats M, Muniz E, Clopes A . Hematopoietic allogeneic transplantation with attenuated conditioning regimen on an outpatient basis. First experience in Spain Med Clin (Barc) 2001 116: 580 582","journal-title":"Med Clin (Barc)"},{"key":"BF1703819_CR17","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1056\/NEJM200104053441402","volume":"344","author":"BJ Druker","year":"2001","unstructured":"Druker BJ, Sawyers CL, Kantarjian H et al. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome New Engl J Med 2001 344: 1038 1042","journal-title":"New Engl J Med"},{"key":"BF1703819_CR18","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1056\/NEJM200104053441401","volume":"344","author":"BJ Druker","year":"2001","unstructured":"Druker BJ, Talpaz M, Resta DJ et al. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia New Engl J Med 2001 344: 1031 1037","journal-title":"New Engl J Med"},{"key":"BF1703819_CR19","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1056\/NEJMoa011573","volume":"356","author":"H Kantarjian","year":"2002","unstructured":"Kantarjian H, Sawyers C, Hochhaus A et al. Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia New Engl J Med 2002 356: 645 652","journal-title":"New Engl J Med"},{"key":"BF1703819_CR20","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1056\/NEJM200208153470719","volume":"347","author":"G Barbany","year":"2002","unstructured":"Barbany G, Hoglund M, Simonsson B . Complete molecular remission in chronic myelogenous leukemia after imatinib therapy New Engl J Med 2002 347: 539 540","journal-title":"New Engl J Med"},{"key":"BF1703819_CR21","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/S0140-6736(02)07831-5","volume":"359","author":"A Gratwohl","year":"2002","unstructured":"Gratwohl A, Baldomero H, Urbano-Ispizua A . Transplantation in chronic myeloid leukemia Lancet 2002 359: 712 713","journal-title":"Lancet"},{"key":"BF1703819_CR22","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1093\/jnci\/92.24.1972","volume":"92","author":"A Twombly","year":"2000","unstructured":"Twombly A . News: Stem cell transplant numbers decline; research continues J Nat Cancer Inst 2000 92: 1972 1973","journal-title":"J Nat Cancer Inst"},{"key":"BF1703819_CR23","doi-asserted-by":"publisher","first-page":"440","DOI":"10.3109\/07357900009032816","volume":"18","author":"RD Baynes","year":"2000","unstructured":"Baynes RD, Dansey RD, Klein JL et al. High-dose chemotherapy and autologous stem cell transplantation for breast cancer Cancer Invest 2000 18: 440 455","journal-title":"Cancer Invest"},{"key":"BF1703819_CR24","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1056\/NEJM199512073332305","volume":"333","author":"T Philip","year":"1995","unstructured":"Philip T, Guglielmi C, Hagenbeek A et al. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma New Engl J Med 1995 333: 1540 1545","journal-title":"New Engl J Med"},{"key":"BF1703819_CR25","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1056\/NEJM199607113350204","volume":"335","author":"M Attal","year":"1996","unstructured":"Attal M, Harousseau JL, Stoppa AM et al. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Fran\u00e7ais du Myelome New Engl J Med 1996 335: 91 97","journal-title":"New Engl J Med"},{"key":"BF1703819_CR26","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1056\/NEJM199910143411601","volume":"341","author":"KK Matthay","year":"1999","unstructured":"Matthay KK, Villablanca JG, Seeger RC et al. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group New Engl J Med 1999 341: 1165 1173","journal-title":"New Engl J Med"},{"key":"BF1703819_CR27","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1056\/NEJM199501263320403","volume":"332","author":"RA Zittoun","year":"1995","unstructured":"Zittoun RA, Mandelli F, Willemze R et al. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell\u2019 Adulto (GIMEMA) Leukemia Cooperative Groups New Engl J Med 1995 332: 217 223","journal-title":"New Engl J Med"},{"key":"BF1703819_CR28","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/S0140-6736(96)90536-X","volume":"347","author":"N Schmitz","year":"1996","unstructured":"Schmitz N, Linch DC, Dreger P, Goldstone AH . Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients Lancet 1996 347: 353 357","journal-title":"Lancet"},{"key":"BF1703819_CR29","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1056\/NEJM200101183440303","volume":"344","author":"WI Bensinger","year":"2001","unstructured":"Bensinger WI, Martin PJ, Storer B et al. Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers New Engl J Med 2001 344: 175 181","journal-title":"New Engl J Med"},{"key":"BF1703819_CR30","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1182\/blood-2001-12-0304","volume":"100","author":"N Schmitz","year":"2002","unstructured":"Schmitz N, Beksac M, Hasenclever D et al. Transplantation of mobilized peripheral blood cells to HLA-identical siblings with standard-risk leukemia Blood 2002 100: 761 767","journal-title":"Blood"},{"key":"BF1703819_CR31","first-page":"903","volume":"90","author":"P Anderlini","year":"1997","unstructured":"Anderlini P, Korbling M, Dale D et al. Allogeneic blood stem cell transplantation: considerations for donors Blood 1997 90: 903 908","journal-title":"Blood"},{"key":"BF1703819_CR32","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1056\/NEJM199708073370602","volume":"337","author":"E Gluckman","year":"1997","unstructured":"Gluckman E, Rocha V, Boyer-Chammard A et al. Outcome of cord-blood transplantation from related and unrelated donors New Engl J Med 1997 337: 373 381","journal-title":"New Engl J Med"},{"key":"BF1703819_CR33","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1182\/blood-2002-01-0294","volume":"100","author":"JE Wagner","year":"2002","unstructured":"Wagner JE, Barker JN, DeFor TE et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival Blood 2002 100: 1611 1618","journal-title":"Blood"},{"key":"BF1703819_CR34","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1038\/sj.bmt.1702652","volume":"26","author":"P Ebbeson","year":"2000","unstructured":"Ebbeson P, Gratwohl A, Hows J, ten Have H . Autologous cord blood transplantation. A procedure with potential beyond bone marrow replacement? Bone Marrow Transplant 2000 26: 1129 1130","journal-title":"Bone Marrow Transplant"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1703819","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1703819.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1703819.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T19:21:01Z","timestamp":1648063261000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1703819"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,12,1]]},"references-count":34,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2002,12,1]]}},"alternative-id":["BF1703819"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1703819","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,12,1]]},"assertion":[{"value":"1 October 2002","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2002","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2002","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}